Introduction
In Parkinson's disease, the degeneration of the mesostriatal PET studies on the striatum, a region with very high dopaminergic activity. Recently, Rakshi and colleagues, using pathway leads to progressive loss of presynaptic dopaminergic nerve terminals in the striatum. The loss of striatal modern 3D Fdopa-PET and statistical parametric mapping (SPM), reported that extrastriatal changes in the dopaminergic activity in Parkinson's disease can be quantified in vivo using PET with 6-[ 18 F]fluoro-L-dopa (Fdopa) as monoaminergic function can also be localized in Parkinson's disease patients (Rakshi et al., 1999) . In a sample of seven radioligand (Nahmias et al., 1985; Firnau et al., 1986) . The decline in Fdopa uptake is pronounced in the putamen hemiparkinsonian early Parkinson's disease patients, they made an unexpected finding of a possible compensatory 32-contralateral to the clinically more affected side in Parkinson's disease (Nahmias et al., 1985) and the uptake decreases with 36% increase in Fdopa uptake in the anterior cingulate gyrus of the medial frontal cortex. The significance of the finding increasing motor disability (Leenders et al., 1986a, b; Brooks et al., 1990) . Striatal Fdopa uptake seems to reflect, among is not clear, but because five of the seven patients had been medicated with levodopa, a medication effect in early other things, the number of functioning nerve terminals in the striatum (Snow et al., 1993) .
Parkinson's disease cannot be excluded. To find out if the paradoxical increase in frontal Fdopa The relatively low sensitivity and spatial resolution of early PET scanners focused the main interest in dopaminergic uptake in early Parkinson's disease is drug-induced or disease-related, we studied 20 drug-naive early Parkinson's disease reference to the orbitomeatal line. Before scanning, a cannula was placed in an antecubital vein for radioligand injection. patients using standard region-of-interest (ROI)-based analysis and 3D-mode PET with MRI co-registration. Because A sterile solution containing on average 168 MBq (SD ϭ 24 MBq) of Fdopa was injected intravenously as a bolus. Parkinson's disease (Kuopio et al., 1999) and many other disorders (Brown and Gershon, 1993; Di Paolo, 1994; Epperson et al., 1999) with a known or proposed association with dopaminergic neurotransmission exhibit sex differences
Data analysis
The ROI analysis was carried out by delineating the medial at the clinical level, we studied men and women separately.
frontal cortex [including the anterior cingulate gyrus (Brodmann areas 24 and 32)], mid-dorsolateral prefrontal cortex (area 46), caudate nucleus, putamen, ventral striatum
Subjects and methods
and occipital cortex in each hemisphere as separate ROIs.
Subjects
To exclude structural lesions and for anatomical reference, Ten female patients with early Parkinson's disease, 10 male each individual underwent a brain MRI scan (Magnetom patients with early Parkinson's disease, nine healthy female 1.5 T; Siemens, Erlangen, Germany). PET and MRI planes subjects and seven healthy male subjects were studied. The were realigned with a surface-fit computer program (Pelizzari severity of Parkinson's disease was assessed according to the et al., 1989) so that the planes corresponded in the axial and motor part of the Unified Parkinson's Disease Rating Scale transaxial positions. After realignment, ROIs were drawn on (UPDRS) (Fahn et al., 1987) . There were no significant the MRI and transferred to the corresponding PET images. differences in the severity measured with UPDRS between Fdopa influx rate constants (K i occ ) were calculated with a men and women with Parkinson's disease (Table 1) . Five of multiple time graphical analysis method (Patlak and Blasberg, the women with Parkinson's disease and two of the men 1985), modified to use a non-specific tissue (occipital cortex) with Parkinson's disease had predominantly left-sided rather than the plasma input function, with a procedure symptoms. The rest had predominantly right-sided symptoms.
described previously (Brooks et al., 1990; Burn et al., 1992 ; Three of the 32 subjects were left-handed (two female Ruottinen et al., 1997) . The visual examination of the Patlak controls, one female Parkinson's disease patient) and one plots indicated that the Patlak method could also be used for subject was ambidextrous (male control). None of the the extrastriatal regions. Parkinson's disease patients had received any anti-
The statistical computations were performed with SAS parkinsonian medication. All female participants were over System for Windows 6.10 (SAS, Cary, NC, USA). The the age of normal menopause except one control woman differences between age, UPDRS and Fdopa K i occ were (age 50 years) and one woman with Parkinson's disease (age analysed by two-way analysis of variance with respect to sex 47 years). None of the subjects had major depression.
differences. Differences in the average level of corresponding However, because no quantitative measurements of the measurements on opposite hemispheres were tested with the affective state were carried out, a mild dysthymic state cannot matched pairs t test. 
Results
Women with Parkinson's disease had 87% higher Fdopa values in the right dorsolateral prefrontal cortex (area 46)
PET imaging
Electrophilic [ 18 F]F 2 was produced according to Bergman compared with men with Parkinson's disease, while there was no sex difference in the control group (sex ϫ disease and Solin . Fdopa was synthesized according to the method of Namavari and colleagues interaction, P ϭ 0.03) ( Table 1) . The values in the right dorsolateral prefrontal cortex were higher in both men with (Namavari et al., 1992) and Bergman and colleagues (Bergman et al., 1994) . The radiochemical purity exceeded Parkinson's disease (82% higher) and women with Parkinson's disease (219% higher) than in the control groups 98% in every case. For premedication, to block peripheral decarboxylation of Fdopa, all subjects received carbidopa.
( Fig. 1 and Table 1 ). Also in the left dorsolateral prefrontal cortex and in the medial frontal cortex, early Parkinson's Dynamic 90-min PET scans were performed with a GE Advance PET Scanner (General Electric Medical Systems, disease patients had 18-94% higher Fdopa uptake compared with healthy controls (Table 1 ). In the contra-and ipsilateral Milwaukee, Wis., USA) in the 3D scanning mode (septa retracted). The 3D performance of the scanner has been putamen and in the contralateral caudate, both men and women with Parkinson's disease had 27-46% lower Fdopa described elsewhere (Lewellen et al., 1996) . The subjects were positioned in the scanner with 3D laser alignment with K i occ values compared with healthy controls ( 
Discussion
This study documents an increase in Fdopa uptake in the frontal cortex in early Parkinson's disease. The increase was significant in all frontal cortical regions studied in early Parkinson's disease compared with healthy controls. The Fdopa uptake in the right dorsolateral prefrontal cortex was 87% higher in women with early Parkinson's disease compared with men with early Parkinson's disease. colleagues (Rakshi et al., 1999) reported increased Fdopa uptake in the left medial frontal cortex (Brodmann areas 24 patients and to studies using Fdopa as radioligand. We have seen no significant changes in the frontal dopamine D 2 /D 3 and 32) and in the dorsal midbrain in seven early Parkinson's disease patients. In the present study, using a standard ROIreceptors (Kaasinen et al., 2000) or in the frontal presynaptic dopamine reuptake sites (Rinne et al., 1999) using 3D PET based analysis and 3D Fdopa-PET, we similarly report increased uptake in the medial frontal cortex (areas 24 and in unmedicated early Parkinson's disease patients. Moreover, in advanced Parkinson's disease no significant change (Rakshi 32) and additionally in the dorsolateral prefrontal cortex in 20 Parkinson's disease patients. It is not clear why, in the et al., 1999) or decline in the frontal Fdopa uptake has been seen. Striatal Fdopa accumulation study by Rakshi and colleagues, no differences were seen in the dorsolateral prefrontal cortex. A possible reason is the can reflect the transport of Fdopa into nigrostriatal nerve terminals, the activity of dopa decarboxylase, the storage of relatively high variability of Fdopa K i occ in the dorsolateral prefrontal cortex compared with other cortical regions 6-[ 18 F]fluorodopamine within vesicles (Firnau et al., 1987; Hoshi et al., 1993) and/or the number of functioning nerve (Table 1 ) and the smaller number of subjects in the earlier study. Moreover, five of the seven early Parkinson's disease terminals (Snow et al., 1993) . The increase in frontal Fdopa uptake in early Parkinson's disease may most likely be a patients in the earlier study had been medicated and the sex of the subjects is not reported. The main finding, however, reflection of increased aromatic amino acid decarboxylase activity (Rakshi et al., 1999) . Because aromatic amino acid is the same in the present study and in the study by Rakshi and colleagues: increased frontal Fdopa uptake in early decarboxylase is also present in serotonergic and noradrenergic neurones, cortical Fdopa uptake cannot be Parkinson's disease. Parkinson's disease is neurochemically characterized by a dopamine loss in the striatum. The considered specific to the dopamine system. increased frontal Fdopa uptake is paradoxical in the sense that Parkinson's disease is considered a hypodopaminergic syndrome.
Sex difference
In addition to the overall increase in Fdopa uptake in the Although the Fdopa uptake in the right dorsolateral prefrontal cortex was increased by up to 219% in early frontal cortex in early Parkinson's disease, we report a sex difference in prefrontal monoaminergic activity in early Parkinson's disease compared with controls in the present study, it should be noted that the mean striatal Fdopa uptake Parkinson's disease. Dopamine neurotransmission is modulated by sex steroids (Di Paolo, 1994) and ovarian in healthy individuals was over 20 times higher than in the prefrontal cortex Fdopa uptake. Thus, the largest absolute hormones may have a role maintaining the normal balance between the neurotransmitter systems in the dorsolateral change in Fdopa uptake in early Parkinson's disease was seen in the putamen, where the absolute decline was five prefrontal cortex (Kritzer and Kohama, 1999) . There are conspicuous sex differences in disorders that have been times greater than the absolute increase in Fdopa uptake in the prefrontal cortex. Nevertheless, the relative increase in linked to a dysfunction in the dopaminergic system (Di Paolo, 1994) . In Parkinson's disease, a recent epidemiological study the prefrontal areas was robust and statistically significant and has potential functional importance. The significance of revealed a substantial increase in the occurrence of Parkinson's disease in men, whereas the prevalence among increased frontal Fdopa uptake in early Parkinson's disease is unclear, but there are several possibilities, which were women remained stable (Kuopio et al., 1999) . There are indications that clinical sex differences in Parkinson's disease discussed earlier by Rakshi and colleagues (Rakshi et al., 1999) . One possibility is a compensatory mechanism in the emerge as the disease progresses, men exhibiting more severe parkinsonian motor features and women experiencing more mesofrontal monoaminergic projections secondary to the degeneration of the mesostriatal projections. The results of levodopa-induced dyskinesia (Lyons et al., 1998) . Sex may also play a role in determining the frequency and treatment the present study indicate, however, that there is no inverse relationship with frontal and striatal Fdopa uptake in early of behavioural problems in nursing home residents with Parkinson's disease (Fernandez et al., 2000) . Depression Parkinson's disease or in healthy controls. Furthermore, the motor disability was not associated with frontal or striatal occurs in~40% of patients with Parkinson's disease and the female sex may be a risk factor for depression in Parkinson's Fdopa K i occ . This is not surprising because, although striatal Fdopa uptake correlates well with the motor disability in disease (Cummings, 1992) . Diminished drive and motivation seem to be associated with lesions of the cingulate or advanced Parkinson's disease patients (Brooks et al., 1990) , the correlation is often small in early Parkinson's disease as dorsolateral prefrontal cortex (Fuster, 1999) . Neuropsychological, metabolic, clinical, pharmacological and a result of the narrow range of motor disability in the patient sample. However, in the present study both men and women anatomical studies support the involvement of frontal monoaminergic projections in patients with Parkinson's with early Parkinson's disease had lower Fdopa uptake in the putamen, caudate and ventral striatum contralateral to the disease and depression. Our study was carried out with early Parkinson's disease patients with no antiparkinsonian predominant symptoms of the disease.
The sum of the available information indicates that the medication or major depression. We hypothesize that the sex difference in the prefrontal cortex monoamine system in increase in frontal monoaminergic activity in Parkinson's disease is restricted to recently diagnosed Parkinson's disease early Parkinson's disease is linked to clinical sex differences which is pronounced in the right dorsolateral prefrontal 490-6. cortex in female patients. Because unmedicated patients were Firnau G, Garnett ES, Chirakal R, Sood S, Nahmias C, Schrobilgen studied, the increase seems to be disease-related rather than neuropsychology and emotion in Parkinson's disease together [Review] . Acta Psychiatr Scand Suppl 1999; 395: 51-7.
with 3D Fdopa PET, with the focus on the extrastriatal regions. 
